Therapeutic Area | MeSH |
---|---|
cardiovascular diseases | D002318 |
nutritional and metabolic diseases | D009750 |
Indication | Ontology | MeSH | ICD-10 |
---|---|---|---|
hypercholesterolemia | — | D006937 | — |
coronary artery disease | — | D003324 | I25.1 |
hypertriglyceridemia | EFO_0004211 | D015228 | — |
hyperlipoproteinemias | — | D006951 | — |
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
---|---|---|---|---|---|---|---|---|---|
Hypertriglyceridemia | D015228 | EFO_0004211 | — | 3 | 3 | 13 | 7 | 5 | 30 |
Healthy volunteers/patients | — | — | — | 13 | — | — | 1 | 11 | 25 |
Cardiovascular diseases | D002318 | EFO_0000319 | I98 | — | — | 2 | 3 | 7 | 12 |
Pain | D010146 | EFO_0003843 | R52 | 2 | — | — | 4 | 6 | 12 |
Covid-19 | D000086382 | — | U07.1 | — | 1 | 3 | 4 | 1 | 9 |
Diabetes mellitus | D003920 | EFO_0000400 | E08-E13 | — | 2 | 2 | 3 | 3 | 9 |
Type 2 diabetes mellitus | D003924 | EFO_0001360 | E11 | 1 | 1 | 2 | 3 | 1 | 8 |
Myocardial infarction | D009203 | EFO_0000612 | I21 | — | — | 3 | 2 | 3 | 8 |
Myocardial ischemia | D017202 | EFO_1001375 | I20-I25 | — | — | 2 | 3 | 3 | 8 |
Coronary artery disease | D003324 | — | I25.1 | — | — | 2 | 4 | 2 | 8 |
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
---|---|---|---|---|---|---|---|---|---|
Carcinoma | D002277 | — | C80.0 | 7 | 16 | 7 | — | 2 | 31 |
Recurrence | D012008 | — | — | 13 | 13 | 3 | — | 4 | 30 |
Neoplasms | D009369 | — | C80 | 13 | 13 | 1 | — | — | 24 |
Lung neoplasms | D008175 | — | C34.90 | 3 | 13 | 6 | — | 1 | 20 |
Non-small-cell lung carcinoma | D002289 | — | — | 3 | 8 | 6 | — | 1 | 17 |
Syndrome | D013577 | — | — | 6 | 9 | 2 | — | 1 | 15 |
Neuroendocrine tumors | D018358 | EFO_1001901 | D3A.8 | 1 | 10 | 2 | — | — | 13 |
Adenocarcinoma | D000230 | — | — | 4 | 6 | 2 | — | 1 | 12 |
Alzheimer disease | D000544 | EFO_0000249 | F03 | 2 | 2 | 5 | — | 1 | 9 |
Carcinoid tumor | D002276 | — | D3A.00 | 1 | 5 | 1 | — | 1 | 8 |
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
---|---|---|---|---|---|---|---|---|---|
Lymphoma | D008223 | — | C85.9 | 15 | 7 | — | — | — | 17 |
Breast neoplasms | D001943 | EFO_0003869 | C50 | 8 | 8 | — | — | — | 13 |
Liver diseases | D008107 | EFO_0001421 | K70-K77 | 6 | 3 | — | — | 1 | 9 |
Leukemia | D007938 | — | C95 | 8 | 4 | — | — | — | 8 |
Pancreatic neoplasms | D010190 | EFO_0003860 | C25 | 5 | 5 | — | — | — | 8 |
Non-hodgkin lymphoma | D008228 | — | C85.9 | 7 | 2 | — | — | — | 7 |
Follicular lymphoma | D008224 | — | C82 | 6 | 3 | — | — | — | 7 |
B-cell chronic lymphocytic leukemia | D015451 | — | C91.1 | 6 | 2 | — | — | — | 6 |
Large b-cell lymphoma diffuse | D016403 | — | C83.3 | 6 | 1 | — | — | — | 6 |
B-cell lymphoma | D016393 | — | — | 6 | 1 | — | — | — | 6 |
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
---|---|---|---|---|---|---|---|---|---|
Alcohol drinking | D000428 | EFO_0004329 | — | 2 | — | — | — | 2 | 4 |
Pulpitis | D011671 | EFO_1001139 | K04.0 | 1 | — | — | — | 2 | 3 |
Myeloid leukemia acute | D015470 | — | C92.0 | 2 | — | — | — | — | 2 |
Hematologic neoplasms | D019337 | — | — | 2 | — | — | — | — | 2 |
Myeloid leukemia | D007951 | — | C92 | 2 | — | — | — | — | 2 |
Hepatic insufficiency | D048550 | — | — | 2 | — | — | — | — | 2 |
Tongue neoplasms | D014062 | EFO_0003871 | C02.9 | 2 | — | — | — | — | 2 |
Laryngeal neoplasms | D007822 | EFO_0003817 | C32 | 2 | — | — | — | — | 2 |
Verrucous carcinoma | D018289 | — | — | 2 | — | — | — | — | 2 |
Laryngeal diseases | D007818 | — | J38.7 | 2 | — | — | — | — | 2 |
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
---|---|---|---|---|---|---|---|---|---|
Back pain | D001416 | — | M54 | — | — | — | — | 3 | 3 |
Uterine cervical neoplasms | D002583 | — | — | — | — | — | — | 3 | 3 |
Dental caries | D003731 | EFO_0003819 | K02 | — | — | — | — | 3 | 3 |
Flatfoot | D005413 | EFO_0003874 | M21.4 | — | — | — | — | 3 | 3 |
Keratoconjunctivitis sicca | D007638 | EFO_1000906 | — | — | — | — | — | 2 | 2 |
Dry eye syndromes | D015352 | — | H04.12 | — | — | — | — | 2 | 2 |
Low back pain | D017116 | — | M54.5 | — | — | — | — | 2 | 2 |
Alcoholism | D000437 | EFO_0003829 | F10.1 | — | — | — | — | 2 | 2 |
Anesthesia | D000758 | — | — | — | — | — | — | 2 | 2 |
Rheumatoid arthritis | D001172 | EFO_0000685 | M06.9 | — | — | — | — | 2 | 2 |
Drug common name | Clofibrate |
INN | calcium clofibrate |
Description | Clofibrate is the ethyl ester of clofibric acid. It has a role as an anticholesteremic drug, an antilipemic drug, a geroprotector and a PPARalpha agonist. It is an aromatic ether, a member of monochlorobenzenes and an ethyl ester. It is functionally related to a clofibric acid. |
Classification | Small molecule |
Drug class | antihyperlipidemics (clofibrate type) |
Image (chem structure or protein) | ![]() |
Structure (InChI/SMILES or Protein Sequence) | CCOC(=O)C(C)(C)Oc1ccc(Cl)cc1 |
PDB | — |
CAS-ID | 637-07-0 |
RxCUI | — |
ChEMBL ID | CHEMBL565 |
ChEBI ID | 3750 |
PubChem CID | 2796 |
DrugBank | DB00636 |
UNII ID | TT85QFR500 (ChemIDplus, GSRS) |